Physicians

Departments / Divisions

• Medicine / Medicine - Oncology
• Radiation Oncology

Address
DUMC 3893
Durham, NC 27710

Appointment Telephone
919-660-9672

Office Telephone
919-668-1748

Fax Telephone
919-681-0874

Training

• MD, Mayo Medical School (Minnesota), 1994

Residency

• Internal Medicine, Duke University Medical Center, 1997

Fellowship

• Hematology-Oncology, Duke University Medical Center, 2000

Clinical Interests
Breast cancer angiogenesis, breast cancer in younger women, hormonal therapy, neoadjuvant therapy for breast cancer

Research Interests
Breast cancer angiogenesis
Breast cancer in younger women
Hormonal therapy
Neoadjurant therapy for breast cancer

Current Clinical Investigations

Principal Investigator, A Phase I-II Study of Neoadjuvant Evacet/Paclitaxel/Hyperthermia in Locally Advanced Breast Cancer Patients.

Investigator, Development of Screening Markers for Breast Cancer using Circulating Immune Complexes: Collaborative Study with Diagen Medical Technologies.

Principal Investigator, Use of Plasma D-Dimer as a Predictive Marker in Colorectal Carcinoma: Correlative Science Study with Genentech, Inc.

Principal Investigator, A randomized, Phase II study of gabapentin or glutamine to prevent the peripheral neuropathy/myalgia associated with weekly taxol administration in metastatic breast and lung cancer.

Investigator, A Phase 2, Randomized, Double-Masked, Multicenter Study of Two Dose Levels of ERA-923 for the treatment of Metastatic Breast Cancer in Postmenopausal Women who have failed Tamoxifen therapy. Genetics Institute.

Investigator, A Phase I Study of Combined Doxil/Hyperthermia in Stage IV Breast Cancer.

Industry Relationships and Collaborations (What's this?)

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

• Advanced Health Media
• Amgen, Inc.
• Caravel Group
• Envision Communications
• Leerink Swann and Company
• MedLearning
• Novartis
• Philips Gilmore Oncology Communications
• Prime Education
• Research To Practice
• Shumaker Loop and Kendrick
• Statistical Collaborative, Inc
• TRM Oncology Inc
• chesapeake biotech partners llc
• clinical care options llc
• georgia society of clinical oncology
• gsk holdings america inc
• norcal
• physician education resources llc